Related Experiment Video
Updated: Jun 21, 2026

Intradermal Inoculation of Mycobacterium avium in the Mouse Ear
Published on: July 3, 2025
The origin and spread of a mumps epidemic: United kingdom, 2003-2006
Hershel Jick1, Douglas P Chamberlin, Katrina Wilcox Hagberg
1Boston Collaborative Drug Surveillance Program, Boston University School of Medicine, Lexington, MA 02421, USA. hjick@bu.edu
Background:
The United Kingdom (UK) underwent a massive epidemic of mumps from 2003 through 2006. The origin and spread was mapped in 350 general practices that used office computers to contribute comprehensive medical information on approximately 3 million patients to the General Practice Research Database (GPRD).
Methods:
The continuous 3-month cumulative incidence of mumps (2003-2006) was estimated by dividing the number of diagnosed cases of mumps each 3 months by the population at risk according to age, region, practice, and calendar time. The effect of the measles, mumps, and rubella (MMR) vaccine was estimated by comparing vaccine exposure of those diagnosed with mumps and those who were not.
Results:
There were 5683 cases of mumps recorded in the Database over the 4-year time period. As the Database represents about 5% of the UK population, we estimate that there were more than 100,000 cases of mumps diagnosed in the UK during these 4 years. The epidemic appears to have started in one practice in Wales in the first 6 months of 2003 and then spread slowly north and east, reaching a peak in 2005. Young adults aged 18-24 years were at the highest risk. There were 3 major MMR vaccination campaigns (1988-1989, 1997, and 2004-2005) that by 2006 provided more than 70% protection against mumps in children younger than 18 years of age. Protection was higher in those who had received 2 doses of the vaccine.
Conclusion:
A comprehensive program of medical information generated by selected general practitioners has provided a sound basis for the real-time recording of the origin, spread, and scope of an infectious disease.
Insights
The UK experienced a large mumps epidemic from 2003-2006, primarily affecting young adults. The measles, mumps, and rubella (MMR) vaccine provided significant protection, especially with two doses.
Area of Science:
- Epidemiology
- Public Health
- Immunization
Background:
- The United Kingdom (UK) faced a substantial mumps epidemic between 2003 and 2006.
- Disease surveillance was conducted across 350 general practices, encompassing approximately 3 million patients via the General Practice Research Database (GPRD).
Purpose of the Study:
- To map the origin and spread of the mumps epidemic in the UK.
- To estimate the incidence and identify risk factors for mumps infection.
- To assess the impact of the measles, mumps, and rubella (MMR) vaccine on the epidemic.
Main Methods:
- Calculated the 3-month cumulative incidence of mumps based on diagnosed cases and population at risk.
- Analyzed incidence by age, region, practice, and time.
- Compared MMR vaccine exposure between mumps cases and non-cases to estimate vaccine effectiveness.
Main Results:
- Over 5,683 mumps cases were recorded, estimating over 100,000 cases in the UK.
- The epidemic originated in Wales in 2003, spreading north and east, peaking in 2005.
- Young adults (18-24 years) were at highest risk; the MMR vaccine offered over 70% protection by 2006, with higher efficacy for two doses.
Conclusions:
- The GPRD facilitated real-time recording of infectious disease dynamics.
- This data provided a robust foundation for understanding the mumps epidemic's origin, spread, and scale.
Related Concept Videos
Investigation of Disease Outbreaks
Smallpox
Infectious Diseases and Their Occurrence
Poliomyelitis
Chickenpox
Steps in Outbreak Investigation
